Article written

  • on 19.11.2014
  • at 12:00 AM
  • by admin

RANBAXY SUES USFDA FOR REVOKING DRUG APPROVALS

Nov19

Ranbaxy Laboratories Ltd has sued the US Food and Drug Administration (FDA) for revoking the tentative approvals of Nexium and Valcyte. The FDA has also withdrawn six-month market exclusivity of Valcyte. The USFDA had banned export of drugs manufactured at the plants of Ranbaxy in India to the US. Ranbaxy had paid fines of $500 million in 2013 on seven counts. Sun Pharma is planning to acquire Ranbaxy for $4 billion.

subscribe to comments RSS

Comments are closed